| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Abbott Laboratories (XETRA: ABL)
ABL Technical Analysis
5
| As on 9th Jun 2025 ABL SHARE Price closed @ 116.62 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 102.08 & Strong Buy for SHORT-TERM with Stoploss of 105.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABLSHARE Price
| Open | 117.24 | Change | Price | % |
| High | 117.50 | 1 Day | -1.18 | -1.00 |
| Low | 115.00 | 1 Week | -0.02 | -0.02 |
| Close | 116.62 | 1 Month | 4.16 | 3.70 |
| Volume | 513 | 1 Year | 16.97 | 17.03 |
| 52 Week High 133.20 | 52 Week Low 92.95 | ||||
XETRA Germany Most Active Stocks
| LHAR | 2.05 | -20.23% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BVBA | 0.02 | -60.00% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| AMMN | 8500.00 | 1440578.00% |
| PHIA | 31.36 | 1.92% |
XETRA Germany Top Gainers Stocks
XETRA Germany Top Losers Stocks
| ABL Daily Charts |
ABL Intraday Charts |
Whats New @ Bazaartrend |
ABL Free Analysis |
|
|
ABL Important Levels Intraday
| RESISTANCE | 121.44 |
| RESISTANCE | 119.89 |
| RESISTANCE | 118.94 |
| RESISTANCE | 117.98 |
| SUPPORT | 115.26 |
| SUPPORT | 114.30 |
| SUPPORT | 113.35 |
| SUPPORT | 111.80 |
ABL Forecast June 2025
| 4th UP Forecast | 131.27 |
| 3rd UP Forecast | 126.57 |
| 2nd UP Forecast | 123.67 |
| 1st UP Forecast | 120.76 |
| 1st DOWN Forecast | 112.48 |
| 2nd DOWN Forecast | 109.57 |
| 3rd DOWN Forecast | 106.67 |
| 4th DOWN Forecast | 101.97 |
ABL Weekly Forecast
| 4th UP Forecast | 125.52 |
| 3rd UP Forecast | 122.67 |
| 2nd UP Forecast | 120.90 |
| 1st UP Forecast | 119.14 |
| 1st DOWN Forecast | 114.10 |
| 2nd DOWN Forecast | 112.34 |
| 3rd DOWN Forecast | 110.57 |
| 4th DOWN Forecast | 107.72 |
ABL Forecast2025
| 4th UP Forecast | 201.68 |
| 3rd UP Forecast | 174.4 |
| 2nd UP Forecast | 157.54 |
| 1st UP Forecast | 140.68 |
| 1st DOWN Forecast | 92.56 |
| 2nd DOWN Forecast | 75.7 |
| 3rd DOWN Forecast | 58.84 |
| 4th DOWN Forecast | 31.56 |
Abbott Laboratories ( XETRA Germany Symbol : ABL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABL Business Profile
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service